Fig. 6 | Scientific Reports

Fig. 6

From: NOS2 as a prognostic biomarker for early-onset colorectal cancer based on public data and clinical validation analysis

Fig. 6

Validation analysis of NOS2 and its related genes. a-b, Correlation of NOS2 with CXCL1 (a) and CXCL2 (b) in TCGA group. c-d, Correlation of NOS2 with CXCL1 (c) and CXCL2 (d) in GSE39582 group. e, Clinical information for EOCRC in the clinical validation group. f-h, Expression of NOS2 (f), CXCL1 (g), and CXCL2 (h) in EOCRC patients. * p < 0.05. ** p < 0.01. *** p < 0.001.

Back to article page